TCM informs about board meeting

26 May 2018 Evaluate

TCM has informed about the board at their meeting held today has approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2018, and recommend the final dividend of Re 0.30 (i.e. 30%) per equity share of the face value of Re 1 each for the financial year ended 31st March, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

TCM Share Price

69.52 -2.78 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×